Vols. Videos

Subependymal Giant Cell Astrocytoma

Last Updated: May 8, 2021

Open Table of Contents: Subependymal Giant Cell Astrocytoma

Figure 1: This subependymal giant-cell astrocytoma (SEGA) is present in its typical location at the foramen of Monro. This lesion is larger than should be seen for other subependymal nodules in tuberous sclerosis. (Left) A FLAIR image demonstrates multiple subcortical hyperintense tubers. A hyperintense right posterior periventricular nodule is also visible. Other calcified subependymal nodules are less evident. (Right) Postcontrast T1WI demonstrates the avid enhancement typical of SEGAs.

Figure 1: This subependymal giant-cell astrocytoma (SEGA) is present in its typical location at the foramen of Monro. This lesion is larger than should be seen for other subependymal nodules in tuberous sclerosis. (Left) A FLAIR image demonstrates multiple subcortical hyperintense tubers. A hyperintense right posterior periventricular nodule is also visible. Other calcified subependymal nodules are less evident. (Right) Postcontrast T1WI demonstrates the avid enhancement typical of SEGAs.

BASIC DESCRIPTION

  • Benign tumor of neuroglial origin classically arising in patients with tuberous sclerosis complex (TSC)
  • Slow-growing tumor arising in region of germinal matrix, usually near the foramen of Monro, where it can obstruct ventricular outflow, resulting in noncommunicating hydrocephalus
ADVERTISEMENT

Atlas Choice Tapered Pattie Collection

Low-profile for maximal visualization and protection

Tapered shape designed for retractorless surgery

Unparalleled flexibility and non-stick features

LEARN MORE AND SHOP ONLINE

PATHOLOGY

  • WHO grade I
  • May arise from subependymal nodules (SENs) near germinal matrix
    • Represents a neuroglial migration abnormality
  • Most common are CNS tumors in patients with TSC
    • Uncommonly arises in the absence of TSC
  • Similar histology to SENs with diagnosis of SEGA based on tumor size and growth
  • Autosomal dominant inheritance or de novo mutations of TSC1 and TSC2 genes

CLINICAL FEATURES

  • Afflicts children and young adults with TSC (mean age, 11 years)
  • Presenting symptoms
    • Obstructive hydrocephalus
    • Headache, nausea, vomiting from increased intracranial pressure
    • Rarely, spontaneous tumoral hemorrhage with intraventricular extension
    • Worsening seizures/epilepsy
  • Good prognosis/curable with total surgical resection
  • Treatment: rapamycin and/or surgical resection

IMAGING FINDINGS

  • General
    • Slowly enlarging, avidly enhancing mass arising near the lateral ventricles/foramen of Monro in patients with TSC
    • Well-defined tumor margins, often lobulated or “frond-like”
    • Variable size
    • Additional findings of TSC (cortical tubers/dysplasias, SENs)
  • CT
    • Heterogeneously hypodense to isodense to gray matter
    • May show calcification, hydrocephalus
    • Strong but heterogeneous enhancement on contrast-enhanced CT imaging
  • MRI
    • T1WI: hypointense to isointense to gray matter; areas of calcification can appear hyperintense
    • T2WI: heterogeneously isointense to hyperintense; calcification appearing hypointense
    • FLAIR: heterogeneously hyperintense, periventricular hyperintensity secondary to acute hydrocephalus and transependymal flow of cerebrospinal fluid
    • T2*/GRE/SWI: black susceptibility artifact from foci of calcification
    • T1WI+C: avid enhancement
    • DWI: relatively reduced diffusion compared with TSC hamartomas

IMAGING RECOMMENDATIONS

  • MRI with contrast, imaging surveillance of enlarging SENs/SEGA

For more information, please see the corresponding chapter in Radiopaedia.

Contributor: Rachel Seltman, MD

DOI: https://doi.org/10.18791/nsatlas.v1.03.01.38

References

Kalantari BN, Salamon N. Neuroimaging of tuberous sclerosis: spectrum of pathologic findings and frontiers in imaging. AJR Am J Roentgenol 2008;190: W304–W309. doi.org/10.2214/AJR.07.2928.

Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109. doi.org/10.1007/s00401-007-0243-4.

Osborn AG, Salzman KL, Jhaveri MD. Diagnostic Imaging (3rd ed). Elsevier, Philadelphia, PA; 2016.

Roth J, Roach ES, Bartels U, et al. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 2013;49:439–444. doi.org/10.1016/j.pediatrneurol.2013.08.017.

Sener RN. Diffusion MR imaging of giant cell tumors in tuberous sclerosis. J Comput Assist Tomogr 2003;27:431–433. doi.org/10.1097/00004728-200305000-00023.

Smith A, Smirniotopoulos J, Horkanyne-Szakaly I. From the radiologic pathology archives: intraventricular neoplasms: radiologic-pathologic correlation. Radiographics 2013;33: 21–43. doi.org/10.1148/rg.331125192.

Please login to post a comment.

Top
You can make a difference: donate now. The Neurosurgical Atlas depends almost entirely on your donations: donate now.